Anti-cancer drug opens new way to treat Parkinson's disease
Researchers from several Catalan scientific centers have discovered anti-cancer drug Rucaparib, potential in the body to treat Parkinson's disease due to the
Stay updated with breaking news from Cell Chemical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers from several Catalan scientific centers have discovered anti-cancer drug Rucaparib, potential in the body to treat Parkinson's disease due to the
A research team has detected various substances that have a dual effect against tuberculosis: They make the bacteria causing the disease less pathogenic for human immune cells and boost the activity of conventional antibiotics / publication in ‘Cell Chemical Biology’.
Treating tuberculosis when antibiotics no longer work. Researchers identified virulence blockers that utilize target structures that are distinct from those by classical antibiotics
<p>A research team has detected various substances that have a dual effect against tuberculosis: They make the bacteria causing the disease less pathogenic for human immune cells and boost the activity of conventional antibiotics / publication in ‘Cell Chemical Biology’</p>
Researchers find new antibiotic molecules weakening tuberculosis bacteria